/nodulation/cell division (RND), the proteobacterial antimicrobial compound efflux (PACE) family and the p-aminobenzoyl-glutamate transporter (AbgT) family [1]. Of these, SMR, MFS, MATE, RND, PACE and AbgT use proton kinetic potential as energy and ABC transporters use ATP as energy. All of them can export drugs and other substrates out of cells [2]. Some proteins, although they confer low levels of resistance, are often the first step in resistance, eventually leading to higher resistance by acquiring chromosomal mutations that target antibiotics. The ABC transporter is one of these proteins [3]. ABC transporters exist in almost all organisms from microorganisms to humans [4, 5]. ABC transporters have attracted extensive attention because of their involvement in important physiological processes such as bacterial resistance, human cystic fibrosis, and tumor cell resistance to chemotherapy drugs [6]. ABC transporters contain similar topologies, with two transmembrane domains (TMD) and two nucleotide-binding domains (NBD). These four domains can fuse to form a full transporter such as the multidrug efflux pump P-glycoprotein (P-gp, ABCB1 or MDR1) in humans. In bacteria, multidrug efflux pumps usually fuse to form a half-transporter with a TMD and an NBD domain [7]. The half-transporter forms a homodimer such as MsbA [7] or LmrA [8]. It can also form heterodimers such as EfrCD [9], YheI/YheH [10] and PatA/PatB [11]. The E. coli K-12MG1655 strain genome was predicted to encode 69 ABC transporters. Eleven of the ABC transporters are presumed to be exporters [5, 12]. Efflux systems of the ABC family in E. coli were reported to mainly include capsular polysaccharide transport pump KpsT [13], hemolysin transport pump HlyA [14, 15], macrocyclic lipid drug efflux pump MacAB [16], outer membrane lipoprotein transport pump LolACDE [17-19], multidrug resistance and phospholipid A transporter MsbA [20], micromycin J25 efflux pump YojI [21], and heme efflux pump CcmABC [22]. Drug efflux systems in E. coli that have been reported included MsbA and MacA. MsbA is a multidrug efflux pump and MacAB is a single-drug efflux pump of macrolides[16]. Studies reported on the A putative multidrug efflux gene, yddA, was cloned from the Escherichia coli K-12 strain. A drugsensitive strain of E. coli missing the main multidrug efflux pump AcrB was constructed as a host and the yddA gene was knocked out in wild-type (WT) and drug-sensitive E. coliΔacrB to study the yddA function. Sensitivity to different substrates of WT E.coli, E. coliΔyddA, E. coliΔacrB and E. coliΔacrBΔyddA strains was compared with minimal inhibitory concentration (MIC) assays and fluorescence tests. MIC assay and fluorescence test results showed that YddA protein was a multidrug efflux pump that exported multiple substrates. Three inhibitors, ortho-vanadate, carbonyl cyanide m-chlorophenylhydrazone (CCCP), and reserpine, were used in fluorescence tests. Ortho-vanadate and reserpine significantly inhibited the efflux and increased accumulation of ethidium bromide and norf...